SAN DIEGO -- A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of phlebotomy, a small randomized trial showed. The ...
Please provide your email address to receive an email when new articles are posted on . Induction therapy with twice-weekly rusfertide helped patients with polycythemia vera achieve target hematocrit ...
ORLANDO, Fla. — Rusfertide, a weekly self-injected peptide, maintained control of hematocrit levels and reductions in phlebotomy requirements through 52 weeks in patients with polycythemia vera (PV), ...
Please provide your email address to receive an email when new articles are posted on . Red blood cell counts and hematocrit levels are higher for teens with insulin resistance as they age compared ...
PROVIDENCE, R.I. [Brown University] — Men over 65 with even slightly abnormal red blood cell counts – either too low or too high – are at greater risk of post-operative death or car-diac events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results